Status:
RECRUITING
Hypothyroidism After the TAVI Procedure in Elderly Patients
Lead Sponsor:
Universitair Ziekenhuis Brussel
Conditions:
Hypothyroidism
TAVI
Eligibility:
All Genders
70+ years
Phase:
NA
Brief Summary
Aortic stenosis is highly prevalent in advancing age. The prognosis of this disease has dramatically changed with the surgical replacement of the aortic valve and the trans catheter aortic valve re-pl...
Detailed Description
Aortic stenosis is highly prevalent in advancing age. The prevalence is 2.5% at an age of 75 years and 8.1% at an age of 85 years. The estimated mortality after onset of symptoms (dizziness, syncope, ...
Eligibility Criteria
Inclusion
- Provision of signed and dated, written Informed Consent prior to any study specific proce-dures
- Patient: males and females must be ≥ 70 years old
- Patients who will undergo a TAVI procedure
Exclusion
- \- No obtained signed, dated and written Informed Consent.
- Known thyroid dysfunction (for example: Basedow, Hashimoto,...)
- Patients receiving any of the following: Lithium, Strumazol or a recent treatment of radio-Iode
Key Trial Info
Start Date :
July 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2050
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04831957
Start Date
July 26 2021
End Date
December 31 2050
Last Update
December 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ brussel
Brussels, Belgium, 1090